Stay updated on IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4 in the page footer, indicating a minor update to the page content.
    Difference
    0.1%
    Check dated 2026-05-15T06:10:47.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s interface/release revision number was updated from v3.5.2 to v3.5.3, reflecting a general maintenance/version change rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-04-24T05:43:43.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:33:23.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added the disease term 'Squamous cell carcinoma of the head and neck' and added the 'Genetic and Rare Diseases Information Center' as a resources entry.
    Difference
    0.2%
    Check dated 2026-04-02T15:23:12.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:56:40.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:55:03.000Z thumbnail image

Stay in the know with updates to IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page.